CTU2 and cancer: In summary, this work demonstrated that high CTU2 expression in patients is significantly associated with poor prognosis and highlighted its potential as a biomarker for modulating immune cell infiltration, particularly in immune evasion processes, potentially influencing the response to immunotherapy in human cancers.